Abraham completed his PhD in synthetic organic chemistry at the Universidad Autónoma de Madrid; he is currently a postdoctoral researcher. He has also worked as a medicinal chemist in the TB area at the Drug Discovery Unit (University of Dundee). He held various roles in industry prior to joining the team as a European Union-funded COFUND researcher.
Abraham will focus his research on the optimization of several hits coming from intracellular high-throughput screening (HTS) against Mtb-infected macrophages. He is based at GSK Tres Cantos and his primary objective in the project will be the delivery of new compounds with good activity in macrophages, acceptable ADME and safety profiles, and with a potential indication of in-vivo efficacy for further progression to a lead optimization stage.
In his free time, he enjoys paddle surfing, swimming and using his camera as much as he can.